Jiří Horáček
Professor of Psychiatry; Director of the National Institute of Mental Health (NIMH/NUDZ) and Head of the Center for Advanced Studies of Brain and Consciousness
Data updated
Research Footprint
Jiří Horáček appears in 5 tracked papers (2012–2025), most studied alongside Psilocybin, 2C-X and Placebo, across Schizophrenia, Neuroimaging & Brain Measures and Healthy Volunteers.
Most-cited paper: Sex differences and serotonergic mechanisms in the behavioural effects of psilocin (85 citations).
Frequent co-authors: Tomáš Páleníček, František Tylš and Martin Brunovský.
Background & Research
Jiří Horáček is a Czech psychiatrist, neuroscientist, and psychotherapist affiliated with the National Institute of Mental Health in Klecany and Charles University in Prague. He serves as Director of NUDZ and heads the Center for Advanced Studies of Brain and Consciousness, where his group studies the neurobiology and clinical effects of pharmacologically induced changes in consciousness, including psychedelic research. He is listed as "prof. MUDr. Jiří Horáček, Ph.D., FCMA" on the NUDZ staff page, and NUDZ materials describe him as a professor of psychiatry involved in ongoing psilocybin research.
Key Impact
A leading Czech psychiatrist and neuroscientist whose work spans psychedelics, consciousness, and translational psychopharmacology, including psilocybin and related compounds.
Collaboration Network
7 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Jiří Horáček is associated with.